IL18 and colitis: Likewise, studies conducted by Tian et al. [15] showed that dietary glucoraphanin supplementation in mice used as a colitis model reduced the expression of the inflammatory cytokines IL-1β, IL-18, and TNF-α, activated Nrf2, and alleviated oxidative stress.